Regulus Therapeutics Inc (NASDAQ:RGLS)

17.30
Delayed Data
As of Apr 17
 +0.12 / +0.70%
Today’s Change
5.40
Today|||52-Week Range
25.60
+7.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues13.8M12.7M19.6M7.7M
 
 
 
 
 
Depreciation And Amortization911.0K1.0M1.4M1.5M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses20.0M24.3M36.0M51.1M
 
 
 
 
 
Research And Development17.3M20.3M29.9M41.0M
 
 
 
 
 
Total Operating Expenses20.9M25.3M37.4M52.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.1M-12.6M-17.8M-44.9M
 
 
 
 
 
Extraordinary Charge0.00-4.7M-1.1M-12.1M
 
 
 
 
Interest Expense On Debt388.0K247.0K36.0K39.0K
 
 
 
 
 
Other Expenses1.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.4M-17.4M-18.7M-56.7M
 
 
 
 
 
Income Taxes-206.0K-10.0K-23.0K-1.0K
 
 
 
 
 
Net Income-7.4M-17.4M-18.7M-56.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.1M8.2M38.5M44.1M
 
 
 
 
 
Shares To Calculate EPS Diluted34.1M8.2M38.5M44.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.49-$2.12-$0.49-$1.29
 
 
 
 
 
EPS Diluted-$0.22-$2.12-$0.49-$1.29
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account